Vicore Pharma is a Swedish pharmaceutical company focused on developing treatments for severe lung diseases.
Drugs in development
- C21 - for COVID-19, Idiopathic Pulmonary Fibrosis (IPF) and Pulmonary arterial hypertension (PAH).
- Inhaled IMID - for IPF cough.
- DTx - for IPF anxiety.
- C106 - multiple indications.
